5-HT1A receptor antagonists increase the activity of serotonergic cells in the dorsal raphe nucleus in rats treated acutely or chronically with citalopram
- 1 August 1995
- journal article
- research article
- Published by Springer Nature in Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie
- Vol. 352 (2) , 157-165
- https://doi.org/10.1007/bf00176769
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- The 5-HT1A receptor antagonist (S)-UH-301 blocks the (R)-8-OH-DPAT-induced inhibition of serotonergic dorsal raphe cell firing in the ratJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1994
- Current advances and trends in the treatment of depressionTrends in Pharmacological Sciences, 1994
- Chronic treatment with fluvoxamine increases extracellular serotonin in frontal cortex but not in raphe nucleiSynapse, 1993
- Citalopram's ability to increase the extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortexBrain Research, 1992
- Selective serotonin reuptake inhibitors.BMJ, 1992
- Direct Immunohistochemical Evidence of the Existence of 5‐HT1A Autoreceptors on Serotoninergic Neurons in the Midbrain Raphe NucleiEuropean Journal of Neuroscience, 1990
- (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: a putative 5-HT1A-receptor antagonistJournal of Medicinal Chemistry, 1990
- Electrophysiological responses of serotoninergic dorsal raphe neurons to 5‐HT1A and 5‐HT1B agonistsSynapse, 1987
- Suppression of firing activity of 5-HT neurons in the dorsal raphe by alpha-adrenoceptor antagonistsNeuropharmacology, 1980
- Tolerance of locus coeruleus neurones to morphine and suppression of withdrawal response by clonidineNature, 1978